CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities:
Net income from continuing operations	$ 14,656	$ 23,366
Adjustments to reconcile net income from continuing operations to net cash and cash equivalents provided by operating activities:
Depreciation and amortization	4,941	4,702
Net amortization (accretion) of premiums and discounts	505	(227)
Provision for (recovery of) credit losses	3,411	(4,502)
Origination of loans held for sale	(90,021)	0
Proceeds from sale of loans held for sale	97,326	0
Loss on bank premises and equipment	684	0
Net gains on sale of mortgage loans	(2,790)	0
Earnings on bank-owned life insurance and gain on death benefit	(1,147)	(1,146)
Stock-based compensation expense	959	641
Gain on bank-owned life insurance death benefit	0	(6)
(Gain) loss on other real estate owned	(59)	17
Provision (benefit) for deferred income taxes	(700)	1,161
Net (increase) decrease in other assets	(1,732)	2,098
Net decrease in other liabilities	(2,884)	(3,624)
Net cash and cash equivalents provided by operating activities from continuing operations	23,149	22,480
Investing activities:
Purchases of securities available-for-sale	(32,486)	(84,959)
Proceeds from paydowns, maturities and calls of securities available-for-sale investment securities	27,650	29,693
Proceeds from paydowns, maturities and calls of securities held-to-maturity investment securities	8,478	14,269
Net (increase) decrease of FRB and FHLB stock	(1,168)	1,406
Net (increase) decrease in loans	(396,983)	125,836
Proceeds from bank-owned life insurance death benefit	352	224
Proceeds from sales of other real estate owned, net of improvements	181	1,901
Purchases of bank premises and equipment	(706)	(2,133)
Business acquisition, net of cash acquired	(4,554)	0
Net cash and cash equivalents (used in) provided by investing activities from continuing operations	(399,236)	86,237
Financing activities:
Net (decrease) increase in deposits	(54,896)	374,461
Cash dividends paid on common stock	(7,387)	(7,349)
Proceeds from exercised stock options	279	1,526
Repurchase of restricted stock	(8)	(14)
Extinguishment of senior subordinated notes	0	(20,000)
Proceeds from FHLB advances, net of repayments	25,000	0
Repayment of short-term borrowings acquired	(19,254)	0
Increase (decrease) in securities sold under agreements to repurchase	(76)	(2,717)
Net cash and cash equivalents (used in) provided by financing activities from continuing operations	(56,342)	345,907
Net change in cash and cash equivalents from continuing operations	(432,429)	454,624
Cash flows used in discontinued operation:
Net cash and cash equivalents used in operating activities	0	(63)
Net change in cash and cash equivalents from discontinued operation	0	(63)
Net change in cash and cash equivalents	(432,429)	454,561
Cash and cash equivalents at beginning of period	530,167	196,185
Cash and cash equivalents at end of period	97,738	650,746
Cash payments for:
Interest	12,286	16,710
Income taxes	$ 3,035	$ 6,146